Valuation: Senzime AB

Market Cap 456M 46.23M 40.31M 38.06M 34.56M 64.76M 4.44B 65.03M 176M 2.26B 174M 170M 7.26B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 456M 46.23M 40.31M 38.06M 34.56M 64.76M 4.44B 65.03M 176M 2.26B 174M 170M 7.26B EV / Sales 2026 *
3.57x
EV / Sales 2027 * 2.23x
Free-Float
40.74%
Yield 2026 *
-
Yield 2027 * -
1 day+0.87%
1 week-15.20%
Current month-18.42%
1 month-24.58%
3 months-34.24%
6 months-31.76%
Current year-46.30%
1 week 2.77
Extreme 2.77
3.42
1 month 2.77
Extreme 2.77
3.96
Current year 2.77
Extreme 2.77
6
1 year 2.77
Extreme 2.77
6.6
3 years 2.77
Extreme 2.77
9.6
5 years 2.6
Extreme 2.605
24.8
10 years 2.6
Extreme 2.605
28.5
Manager TitleAgeSince
Chief Executive Officer 53 03/05/2023
Director of Finance/CFO 56 01/01/2022
Chief Tech/Sci/R&D Officer 50 01/01/2023
Director TitleAgeSince
Chairman 53 03/05/2023
Director/Board Member 70 01/01/2016
Director/Board Member 63 05/03/2020
Date Insider Type Main position Quantity % Market Cap. Importance
09/12/25 Buy

Director

15,000 0.0095%
09/12/25 Sell

Director

15,000 0.0095%
28/11/25 Buy

Director

15,900 0.0101%
Change 5-day change 1-year change 3-year change Capi.($)
+0.87%-15.20%-54.76%-62.44% 46.23M
+0.37%+0.65%-24.57%+1.93% 178B
-0.69%+1.29%-3.10%+11.50% 118B
-0.20%-3.98%+6.47%+71.79% 58.92B
-0.24%+1.74%-3.26%-31.97% 49.29B
-0.22%-0.37%+10.27%+40.45% 48.17B
+1.61%+7.61%+32.47%-5.11% 33.72B
-1.49%-2.74% - - 27.76B
-1.17%+4.64%+42.17%-7.72% 25.5B
+1.02%+5.99%+6.51%-15.81% 22.1B
Average -0.01%+0.15%+1.35%+0.29% 56.09B
Weighted average by Cap. -0.08%+1.03%-3.19%+10.46%

Financials

2026 *2027 *
Net sales 128M 12.95M 11.29M 10.66M 9.68M 18.14M 1.24B 18.21M 49.28M 632M 48.64M 47.56M 2.03B 204M 20.68M 18.04M 17.03M 15.46M 28.97M 1.98B 29.1M 78.72M 1.01B 77.7M 75.97M 3.25B
Net income -68.9M -6.99M -6.09M -5.75M -5.22M -9.79M -670M -9.83M -26.59M -341M -26.24M -25.66M -1.1B -36.8M -3.73M -3.25M -3.07M -2.79M -5.23M -358M -5.25M -14.2M -182M -14.02M -13.71M -586M
Net Debt - -
Logo Senzime AB
Senzime AB (publ.) is a Sweden-based company engaged in the development, manufacture and marketing of biosensors for measuring metabolites in biological fluids, such as human blood and cell culture substrates for the pharmaceutical and healthcare segments. The Company focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. As of December 31, 2011, the Company marketed three products, namely SENZ-100G, for continuous analysis of glucose in the fermentation solutions; SENZ-100L, for continuous analysis of lactate in fermentation solutions, and SENZ-200G, for continuous analysis of glucose in blood during intensive care.
Employees
59
Date Price Change Volume
18/09/26 SEK 2.900 +0.87% 539,665
17/09/26 SEK 2.875 -3.85% 547,892
16/09/26 SEK 2.990 -5.23% 416,562
15/09/26 SEK 3.155 -2.62% 209,872
14/09/26 SEK 3.240 -5.26% 125,992

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEZI Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!